Prescription of therapeutic exercise in migraine, an evidence-based clinical practice guideline

La Touche, Roy; Fierro-Marrero, José; Sánchez-Ruíz, Irene; Rodríguez de Rivera-Romero, Borja; Cabrera-López, Carlos Donato; Lerma-Lara, Sergio; Requejo-Salinas, Néstor; de Asís-Fernández, Francisco; Elizagaray-García, Ignacio; Fernández-Carnero, Josué; Matesanz-García, Luís; Pardo-Montero, Joaquín; Paris-Alemany, Alba; Reina-Varona, Álvaro

doi:10.1186/s10194-023-01571-8

The Journal of Headache and Pain

Table 3 PEDro scale for randomized controlled trials with the information regarding each item score and the total score for each randomized controlled trial

From: Prescription of therapeutic exercise in migraine, an evidence-based clinical practice guideline

Studies	Random allocation	Concealed allocation	Comparability of groups at baseline	Participant blinding	Therapist blinding	Assessor blinding	Dropouts	Intention-to-treat analysis	Intergroup statistical comparison	Point measures and variability	Total
Ahmadi et al., 2015 [41]	Yes	No	Yes	No	No	No	No	No	Yes	Yes	4
Aslani et al., 2021 [42]	Yes	No	Yes	No	No	No	No	No	Yes	Yes	4
Benatto et al., 2022 [43]	Yes	Yes	No	No	No	Yes	Yes	No	Yes	Yes	6
Bond et al., 2018 [44]	Yes	Yes	Yes	No	No	No	No	Yes	Yes	Yes	6
Boroujeni et al., 2015 [45]	Yes	No	No	No	No	No	No	No	Yes	Yes	3
Butt et al., 2022 [46]	No	No	Yes	No	No	No	Yes	Yes	Yes	Yes	5
Darabaneanu et al., 2011 [47]	No	No	Yes	No	No	No	No	No	Yes	Yes	3
Dittrich et al., 2008 [48]	Yes	No	Yes	No	No	No	Yes	Yes	Yes	Yes	6
Hanssen et al., 2017 [50]	Yes	No	No	No	No	No	No	No	Yes	Yes	3
Hanssen et al., 2018 [49]	Yes	No	No	No	No	No	No	No	Yes	Yes	3
John et al., 2007 [51]	Yes	No	Yes	No	No	No	Yes	No	Yes	Yes	5
Kisan et al., 2014 [52]	Yes	Yes	No	No	No	No	No	No	Yes	Yes	4
Köseoglu et al., 2003 [53]	No	No	No	No	No	No	Yes	No	No	Yes	2
Kumar et al., 2020 [54]	Yes	Yes	No	No	No	No	No	Yes	Yes	Yes	5
Lemstra et al., 2002 [55]	Yes	Yes	Yes	No	No	No	Yes	Yes	Yes	Yes	7
Luedtke et al., 2020 [56]	No	No	No	No	No	No	Yes	No	Yes	Yes	3
Matin et al., 2022 [57]	Yes	No	No	No	No	No	Yes	No	Yes	Yes	4
Mehta et al., 2021 [58]	Yes	Yes	Yes	No	No	No	Yes	Yes	Yes	Yes	7
Meyer et al., 2016 [59]	No	No	Yes	No	No	No	No	No	Yes	Yes	3
Minen et al., 2020 [60]	Yes	No	Yes	No	No	No	No	No	Yes	Yes	4
Narin et al., 2003 [61]	No	No	Yes	No	No	No	Yes	Yes	Yes	Yes	5
Oliveira et al., 2017 [62]	Yes	No	Yes	No	No	No	Yes	No	Yes	Yes	5
Oliveira et al., 2019 [63]	Yes	No	Yes	No	No	No	Yes	Yes	Yes	Yes	6
Overath et al., 2014 [64]	No	No	No	Yes	No	No	Yes	No	No	Yes	3
Santiago et al., 2014 [65]	Yes	No	Yes	No	No	No	No	No	Yes	Yes	4
Varkey et al., 2009 [66]	No	No	No	No	No	No	Yes	No	No	Yes	2
Varkey et al., 2011 [67]	Yes	Yes	Yes	No	No	No	No	Yes	Yes	Yes	6
Wells et al., 2021 [68]	Yes	Yes	Yes	Yes	No	Yes	No	Yes	Yes	Yes	8
Xie et al., 2022 [69]	Yes	Yes	Yes	No	No	No	No	Yes	Yes	Yes	6

Item 1: Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated in the order in which treatments were received); Item 2: Allocation was concealed; Item 3: The groups were similar at baseline regarding the most important prognostic indicators; Item 4: There was blinding of all subjects; There was blinding of all therapists who administered the therapy; Item 6: There was blinding of all assessors who measured at least one key outcome; Item 7: Measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups; Item 8: All subjects for whom outcome measures were available received the treatment or control condition as allocated, or, where this was not the case, data for at least one key outcome were analyzed by “intention to treat”; Item 9: The results of between-group statistical comparisons are reported for at least one key outcome; Item 10: The study provides both point measures and measures of variability for at least one key outcome; Score: No = 0; Yes = 1. Poor = 0–3 points; Fair = 4–5 points; Good = 6–8 points; Excellent = 9–10 points

Back to article page

ISSN: 1129-2377

Contact us

Submission enquiries: journalsubmissions@springernature.com